Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 3
1985 2
1986 8
1987 5
1988 2
1989 8
1990 9
1991 9
1992 8
1993 11
1994 1
1995 8
1996 16
1997 19
1998 22
1999 22
2000 17
2001 23
2002 13
2003 35
2004 26
2005 23
2006 22
2007 29
2008 32
2009 27
2010 33
2011 28
2012 36
2013 24
2014 18
2015 23
2016 22
2017 15
2018 23
2019 21
2020 21
2021 16
2022 15
2023 9

Text availability

Article attribute

Article type

Publication date

Search Results

668 results

Results by year

Filters applied: . Clear all
Page 1
HIV.
Ghosn J, Taiwo B, Seedat S, Autran B, Katlama C. Ghosn J, et al. Among authors: katlama c. Lancet. 2018 Aug 25;392(10148):685-697. doi: 10.1016/S0140-6736(18)31311-4. Epub 2018 Jul 23. Lancet. 2018. PMID: 30049419 Review.
Daily and on-demand HIV pre-exposure prophylaxis with emtricitabine and tenofovir disoproxil (ANRS PREVENIR): a prospective observational cohort study.
Molina JM, Ghosn J, Assoumou L, Delaugerre C, Algarte-Genin M, Pialoux G, Katlama C, Slama L, Liegeon G, Beniguel L, Ohayon M, Mouhim H, Goldwirt L, Spire B, Loze B, Surgers L, Pavie J, Lourenco J, Ben-Mechlia M, Le Mestre S, Rojas-Castro D, Costagliola D; ANRS PREVENIR Study Group. Molina JM, et al. Among authors: katlama c. Lancet HIV. 2022 Aug;9(8):e554-e562. doi: 10.1016/S2352-3018(22)00133-3. Epub 2022 Jun 27. Lancet HIV. 2022. PMID: 35772417
A 4-days-on and 3-days-off maintenance treatment strategy for adults with HIV-1 (ANRS 170 QUATUOR): a randomised, open-label, multicentre, parallel, non-inferiority trial.
Landman R, de Truchis P, Assoumou L, Lambert S, Bellet J, Amat K, Lefebvre B, Allavena C, Katlama C, Yazdanpanah Y, Molina JM, Petrov-Sanchez V, Gibowski S, Alvarez JC, Leibowitch J, Capeau J, Fellahi S, Duracinsky M, Morand-Joubert L, Costagliola D, Alvarez JC, Girard PM; ANRS 170 QUATUOR study group. Landman R, et al. Among authors: katlama c. Lancet HIV. 2022 Feb;9(2):e79-e90. doi: 10.1016/S2352-3018(21)00300-3. Lancet HIV. 2022. PMID: 35120640 Clinical Trial.
Toxoplasmic ventriculitis.
Mauhin W, Demoule A, Leclercq D, Gasnault J, Paris L, Katlama C, Epelboin L. Mauhin W, et al. Among authors: katlama c. Med Mal Infect. 2016 Mar;46(2):100-3. doi: 10.1016/j.medmal.2015.11.005. Epub 2015 Dec 30. Med Mal Infect. 2016. PMID: 26746327 No abstract available.
Efavirenz urolithiasis.
Izzedine H, Valantin MA, Daudon M, Mohand HA, Caby F, Katlama C. Izzedine H, et al. Among authors: katlama c. AIDS. 2007 Sep 12;21(14):1992. doi: 10.1097/QAD.0b013e3282ef792f. AIDS. 2007. PMID: 17721118 No abstract available.
Dolutegravir for the treatment of HIV.
Katlama C, Murphy R. Katlama C, et al. Expert Opin Investig Drugs. 2012 Apr;21(4):523-30. doi: 10.1517/13543784.2012.661713. Epub 2012 Mar 2. Expert Opin Investig Drugs. 2012. PMID: 22380682 Review.
[Médecine et Maladies Infectieuses. Editorial].
Katlama C, Dellamonica P. Katlama C, et al. Med Mal Infect. 2009 Dec;39(12 Suppl):1. doi: 10.1016/S0399-077X(09)73375-X. Med Mal Infect. 2009. PMID: 20117330 French. No abstract available.
[HIV and cancer : What's new in 2017?].
Gobert A, Veyri M, Poizot-Martin I, Lavolé A, Solas C, Paliche R, Katlama C, Costagliola D, Spano JP. Gobert A, et al. Among authors: katlama c. Bull Cancer. 2018 Mar;105(3):256-262. doi: 10.1016/j.bulcan.2018.02.002. Epub 2018 Mar 13. Bull Cancer. 2018. PMID: 29548534 Review. French.
668 results